Last reviewed · How we verify
WGc-0201 injection — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
WGc-0201 injection (WGc-0201 injection) — West China Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| WGc-0201 injection TARGET | WGc-0201 injection | West China Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- WGc-0201 injection CI watch — RSS
- WGc-0201 injection CI watch — Atom
- WGc-0201 injection CI watch — JSON
- WGc-0201 injection alone — RSS
Cite this brief
Drug Landscape (2026). WGc-0201 injection — Competitive Intelligence Brief. https://druglandscape.com/ci/wgc-0201-injection. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing